© Copyright 2025 American Medical Association. All rights reserved.
Diphtheria toxoid is a vaccine designed to provide long-lasting immunity against diphtheria, a serious bacterial infection. The vaccine works by stimulating the body's immune system to produce antibodies that specifically target and neutralize the toxins produced by the diphtheria bacteria. The process of creating the toxoid involves culturing the bacteria in a controlled liquid medium, followed by purification and inactivation of the toxic substance they produce. This results in a non-live vaccine that is safe for administration. Due to the nature of toxoid vaccines, which do not contain live pathogens, it is essential to administer booster doses periodically to maintain immunity, as the protective effects can diminish over time. The CPT® Code 90719 specifically refers to the diphtheria toxoid vaccine administered via intramuscular injection, and it is important to note that this code solely represents the product used, rather than the administration process or any associated services.
© Copyright 2025 Coding Ahead. All rights reserved.
The diphtheria toxoid vaccine is indicated for the prevention of diphtheria, a potentially life-threatening disease caused by the bacterium Corynebacterium diphtheriae. The vaccine is recommended for individuals to help protect against the disease, particularly in populations at risk or during outbreaks. The following conditions warrant the administration of the diphtheria toxoid:
The administration of the diphtheria toxoid vaccine involves several key procedural steps to ensure safety and efficacy. The following outlines the procedure:
Following the administration of the diphtheria toxoid vaccine, patients may experience mild side effects, such as soreness at the injection site, low-grade fever, or fatigue. These effects are generally short-lived and resolve without intervention. It is important for patients to be informed about these potential reactions and to report any unusual or severe symptoms to their healthcare provider. Additionally, patients should be advised on the importance of receiving booster doses as recommended to maintain immunity against diphtheria. Documentation of the vaccination should be recorded in the patient's medical record, including the date of administration, the vaccine lot number, and the site of injection.
Short Descr | DIPHTHERIA VACCINE IM | Medium Descr | DIPHTHERIA TOXOID INTRAMUSCULAR | Long Descr | Diphtheria toxoid, for intramuscular use | Status Code | Excluded from Physician Fee Schedule by Regulation | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Items and Services Packaged into APC Rates | Type of Service (TOS) | 1 - Medical Care | Berenson-Eggers TOS (BETOS) | O1G - Immunizations/Vaccinations | MUE | Not applicable/unspecified. | CCS Clinical Classification | 228 - Prophylactic vaccinations and inoculations |
Date
|
Action
|
Notes
|
---|---|---|
2016-01-01 | Deleted | Deleted |
2011-01-01 | Changed | Short description changed. |
Pre-1990 | Added | Code added. |